Olux and Methotrexate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Olux (clobetasol propionate) and Methotrexate (methotrexate sodium). Common drug interactions include psoriasis among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Olux and Methotrexate. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Olux?

Olux has active ingredients of clobetasol propionate. eHealthMe is studying from 614 Olux users. Check the latest studies of Olux.

What is Methotrexate?

Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 604,312 Methotrexate users. Check the latest studies of Methotrexate.



On Jul, 13, 2026

44 people who take Olux and Methotrexate together, and have interactions are studied.

Olux and Methotrexate drug interactions.

What are the common drug interactions of Olux and Methotrexate, by gender? *:

female:

  1. Psoriasis (immune-mediated disease that affects the skin)
  2. Drug ineffective
  3. Fatigue (feeling of tiredness)
  4. Hot flush (sudden feelings of heat)
  5. Skin plaque (red, scaly patches to appear on the skin)
  6. Anxiety
  7. Arthralgia (joint pain)
  8. Depression
  9. Dysphagia (a condition in which swallowing is difficult or painful)
  10. Endometrial cancer recurrent

male:

  1. Arthralgia (joint pain)
  2. Psoriasis (immune-mediated disease that affects the skin)
  3. Pain in extremity
  4. Peripheral swelling
  5. Rash
  6. Rash erythematous (redness of the skin)
  7. Rash macular (small, flat red spots)
  8. Skin discolouration (change of skin colour)
  9. Skin exfoliation (removal of the oldest dead skin cells)
  10. Skin hyperpigmentation (disorders affect the colour of your skin)

What are the common drug interactions of Olux and Methotrexate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Diabetes mellitus inadequate control
  2. Gait disturbance
  3. Muscular weakness (muscle weakness)
  4. Narcissistic personality disorder (a personality disorder in which the individual is described as being excessively preoccupied with issues of personal)
  5. Pain
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Psoriasis (immune-mediated disease that affects the skin)
  8. Scab (a hard coating on the skin formed during the wound healing)
  9. Schizoaffective disorder (a mental disorder characterized by disordered thought)
  10. Skin disorder (skin disease)

40-49:

  1. Injection site pain
  2. Migraine (headache)

50-59:

  1. Endometrial cancer recurrent
  2. Endometrial cancer
  3. Endometrial cancer metastatic
  4. Arthralgia (joint pain)
  5. B-cell lymphoma (blood cancer affecting b cells)
  6. Hot flush (sudden feelings of heat)

60+:

  1. Arthralgia (joint pain)
  2. Atrioventricular block first degree (heart block first degree)
  3. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  4. Fatigue (feeling of tiredness)
  5. Gait disturbance
  6. Joint swelling
  7. Pain
  8. Psoriasis (immune-mediated disease that affects the skin)
  9. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  10. Weight increased

What are the existing conditions these people have? *

  1. Psoriasis (immune-mediated disease that affects the skin): 32 people, 72.73%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 15 people, 34.09%
  3. High Blood Pressure: 10 people, 22.73%
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 15.91%
  5. Type 2 Diabetes: 3 people, 6.82%
  6. Diabetes: 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Olux and Methotrexate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Olux and Methotrexate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Olux:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Methotrexate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Olux and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methotrexate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on clobetasol propionate and methotrexate sodium (the active ingredients of Olux and Methotrexate, respectively), and Olux and Methotrexate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: